United States Oncology/Anti-Cancer Drugs Market Report 2019

Table of Contents

United States Oncology/Anti-Cancer Drugs Market Report 2017
1 Oncology/Anti-Cancer Drugs Overview
1.1 Product Overview and Scope of Oncology/Anti-Cancer Drugs
1.2 Classification of Oncology/Anti-Cancer Drugs by Product Category
1.2.1 United States Oncology/Anti-Cancer Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Oncology/Anti-Cancer Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Chemotherapy
1.2.4 Targeted Therapy
1.2.5 Immunotherapy (Biologic Therapy)
1.2.6 Hormonal Therapy
1.2.7 Others
1.3 United States Oncology/Anti-Cancer Drugs Market by Application/End Users
1.3.1 United States Oncology/Anti-Cancer Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Blood Cancer (Leukaemia)
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Skin Cancer
1.3.7 Other Cancers
1.4 United States Oncology/Anti-Cancer Drugs Market by Region
1.4.1 United States Oncology/Anti-Cancer Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
1.4.3 Southwest Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
1.4.5 New England Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
1.4.6 The South Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
1.4.7 The Midwest Oncology/Anti-Cancer Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oncology/Anti-Cancer Drugs (2012-2022)
1.5.1 United States Oncology/Anti-Cancer Drugs Sales and Growth Rate (2012-2022)
1.5.2 United States Oncology/Anti-Cancer Drugs Revenue and Growth Rate (2012-2022)

2 United States Oncology/Anti-Cancer Drugs Market Competition by Players/Suppliers
2.1 United States Oncology/Anti-Cancer Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oncology/Anti-Cancer Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oncology/Anti-Cancer Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Oncology/Anti-Cancer Drugs Market Competitive Situation and Trends
2.4.1 United States Oncology/Anti-Cancer Drugs Market Concentration Rate
2.4.2 United States Oncology/Anti-Cancer Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oncology/Anti-Cancer Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Oncology/Anti-Cancer Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Oncology/Anti-Cancer Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Oncology/Anti-Cancer Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Oncology/Anti-Cancer Drugs Price by Region (2012-2017)

4 United States Oncology/Anti-Cancer Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Oncology/Anti-Cancer Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oncology/Anti-Cancer Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Oncology/Anti-Cancer Drugs Price by Type (2012-2017)
4.4 United States Oncology/Anti-Cancer Drugs Sales Growth Rate by Type (2012-2017)

5 United States Oncology/Anti-Cancer Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Oncology/Anti-Cancer Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Oncology/Anti-Cancer Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Oncology/Anti-Cancer Drugs Players/Suppliers Profiles and Sales Data
6.1 Amgen
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Amgen Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca
6.2.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Roche Diagnostics
6.3.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Roche Diagnostics Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck
6.5.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Novartis
6.6.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 AbbVie
6.7.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 AbbVie Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Sanofi
6.8.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 EIMC United Pharmaceuticals
6.9.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Actavis
6.10.2 Oncology/Anti-Cancer Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Actavis Oncology/Anti-Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Oncology/Anti-Cancer Drugs Manufacturing Cost Analysis
7.1 Oncology/Anti-Cancer Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oncology/Anti-Cancer Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncology/Anti-Cancer Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Oncology/Anti-Cancer Drugs Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Oncology/Anti-Cancer Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oncology/Anti-Cancer Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Oncology/Anti-Cancer Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Oncology/Anti-Cancer Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Oncology/Anti-Cancer Drugs
Figure United States Oncology/Anti-Cancer Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Immunotherapy (Biologic Therapy) Product Picture
Figure Hormonal Therapy Product Picture
Figure Others Product Picture
Figure United States Oncology/Anti-Cancer Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Oncology/Anti-Cancer Drugs by Application in 2016
Figure Blood Cancer (Leukaemia) Examples
Table Key Downstream Customer in Blood Cancer (Leukaemia)
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Gastrointestinal Cancer Examples
Table Key Downstream Customer in Gastrointestinal Cancer
Figure Respiratory/Lung Cancer Examples
Table Key Downstream Customer in Respiratory/Lung Cancer
Figure Skin Cancer Examples
Table Key Downstream Customer in Skin Cancer
Figure Other Cancers Examples
Table Key Downstream Customer in Other Cancers
Figure United States Oncology/Anti-Cancer Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oncology/Anti-Cancer Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oncology/Anti-Cancer Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oncology/Anti-Cancer Drugs Sales Share by Players/Suppliers
Figure 2017 United States Oncology/Anti-Cancer Drugs Sales Share by Players/Suppliers
Figure United States Oncology/Anti-Cancer Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oncology/Anti-Cancer Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Oncology/Anti-Cancer Drugs Revenue Share by Players/Suppliers
Table United States Market Oncology/Anti-Cancer Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Oncology/Anti-Cancer Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Oncology/Anti-Cancer Drugs Market Share of Top 3 Players/Suppliers
Figure United States Oncology/Anti-Cancer Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oncology/Anti-Cancer Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oncology/Anti-Cancer Drugs Product Category
Table United States Oncology/Anti-Cancer Drugs Sales (K Units) by Region (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales Share by Region (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Share by Region (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Market Share by Region in 2016
Table United States Oncology/Anti-Cancer Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Revenue Share by Region (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Revenue Market Share by Region (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Revenue Market Share by Region in 2016
Table United States Oncology/Anti-Cancer Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales (K Units) by Type (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales Share by Type (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Share by Type (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Market Share by Type in 2016
Table United States Oncology/Anti-Cancer Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology/Anti-Cancer Drugs by Type (2012-2017)
Figure Revenue Market Share of Oncology/Anti-Cancer Drugs by Type in 2016
Table United States Oncology/Anti-Cancer Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales (K Units) by Application (2012-2017)
Table United States Oncology/Anti-Cancer Drugs Sales Market Share by Application (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Market Share by Application (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Market Share by Application in 2016
Table United States Oncology/Anti-Cancer Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Oncology/Anti-Cancer Drugs Sales Growth Rate by Application (2012-2017)
Table Amgen Basic Information List
Table Amgen Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure Amgen Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table Roche Diagnostics Basic Information List
Table Roche Diagnostics Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure Roche Diagnostics Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure Merck Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure AbbVie Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table EIMC United Pharmaceuticals Basic Information List
Table EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure EIMC United Pharmaceuticals Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table Actavis Basic Information List
Table Actavis Oncology/Anti-Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Sales Growth Rate (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Sales Market Share in United States (2012-2017)
Figure Actavis Oncology/Anti-Cancer Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology/Anti-Cancer Drugs
Figure Manufacturing Process Analysis of Oncology/Anti-Cancer Drugs
Figure Oncology/Anti-Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oncology/Anti-Cancer Drugs Major Players/Suppliers in 2016
Table Major Buyers of Oncology/Anti-Cancer Drugs
Table Distributors/Traders List
Figure United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Oncology/Anti-Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oncology/Anti-Cancer Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Oncology/Anti-Cancer Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Oncology/Anti-Cancer Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oncology/Anti-Cancer Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources